908 Devices Inc. (MASS) vs NeuroPace, Inc. (NPCE)
908 Devices Inc. and NeuroPace, Inc. are both Medical Devices companies. 908 Devices Inc. and NeuroPace, Inc. are of similar size ($492.7M and $479.5M). NeuroPace, Inc. grew revenue faster over the last twelve months: 21.7% against 13.4%. NeuroPace, Inc. has the higher net margin (−18.6% vs −57.0%) and the higher return on invested capital (−44.6% vs −96.4%). Across the 18 metrics below, NeuroPace, Inc. leads on 11 and 908 Devices Inc. on 7.
Valuation
Profitability
| Metric | MASS | NPCE | Medical Devices median |
|---|---|---|---|
| Gross margin | 52.16% | 78.38% | 56.01% |
| Operating margin | (63.98%) | (13.33%) | (15.03%) |
| Net margin | (56.96%) | (18.58%) | (20.40%) |
| Free cash flow margin | 1.01% | (11.29%) | (7.24%) |
| Return on equity | (25.15%) | (122.05%) | (15.32%) |
| Return on assets | (17.81%) | (18.82%) | (19.72%) |
| Return on invested capital | (96.41%) | (44.64%) | (10.33%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack